Universal Genetic Testing for Cancer Risk Reduction

NARecruitingINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

March 4, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions
Genetic Testing
Interventions
GENETIC

Natera® Empower™ hereditary cancer panel test

The test will be the Natera® Empower™ hereditary cancer panel test and will be collected by saliva.

OTHER

Specialist Referral

Participants with actionable pathogenic variants will be referred to the appropriate specialists (e.g., medical oncologist, gynecologic oncologist, breast surgeon) to discuss risk-reduction strategies and offered genetic counseling

Trial Locations (1)

10016

RECRUITING

NYU Langone Health, New York

All Listed Sponsors
lead

NYU Langone Health

OTHER